Bacterial therapies: completing the cancer treatment toolbox
- 31 October 2008
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Biotechnology
- Vol. 19 (5), 511-517
- https://doi.org/10.1016/j.copbio.2008.08.004
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Functional antibodies produced by oncolytic clostridiaBiochemical and Biophysical Research Communications, 2007
- Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancerProceedings of the National Academy of Sciences of the United States of America, 2007
- Efficacy of gene therapy-delivered cytosine deaminase is determined by enzymatic activity but not expressionBritish Journal of Cancer, 2007
- Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivoBritish Journal of Cancer, 2006
- Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patientsCancer Gene Therapy, 2003
- Insertion or Deletion of the Cheo Box Modifies Radiation Inducibility of Clostridium PromotersApplied and Environmental Microbiology, 2001
- Radio-responsive recA promoter significantly increases TNFα production in recombinant clostridia after 2 Gy irradiationGene Therapy, 2001
- Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicumCancer Gene Therapy, 2001
- Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain ofSalmonella typhimuriumThe Journal of Infectious Diseases, 2000
- Clostridial oncolysis in manEuropean Journal of Cancer (1965), 1967